Delving into the Latest Updates on 广州白云山医药集团股份有限公司白云山化学制药厂 with Synapse

概览

疾病领域	数量

感染	2

排名前五的药物类型	数量

小分子化药	2

排名前五的靶点	数量

Bacterial DNA gyrase x TOP	1

关联

2

项与广州白云山医药集团股份有限公司白云山化学制药厂相关的药物

Pasiniazid

帕司烟肼

靶点-

作用机制-

在研机构

广州白云山医药集团股份有限公司白云山化学制药厂

原研机构

广州白云山医药集团股份有限公司

在研适应症

肺结核

非在研适应症-

最高研发阶段批准上市

首次获批国家/地区

中国

首次获批日期1994-01-01

Ciprofloxacin Lactate

乳酸环丙沙星

靶点

Bacterial DNA gyrase x TOP

作用机制

细菌DNA旋转酶复合体抑制剂 [+1]

在研机构

Baxter Holding BV [+1]

原研机构

Baxter Co. Ltd.

在研适应症

感染

非在研适应症-

最高研发阶段批准上市

首次获批国家/地区

中国

首次获批日期1992-01-01

100 项与广州白云山医药集团股份有限公司白云山化学制药厂相关的临床结果

登录后查看更多信息

0 项与广州白云山医药集团股份有限公司白云山化学制药厂相关的专利（医药）

登录后查看更多信息

12

项与广州白云山医药集团股份有限公司白云山化学制药厂相关的文献（医药）

Guangzhou Huagong

Synthesis process study of 16-dehydropregnenolone acetate oxime

作者: Zhang, Lu-lu ; Shi, Cheng

The 16-dehydropregnenolone acetate oxime was a key intermediate to synthesis many steroids products, such as dehydroepiandrosterone, nandrolone decanoate, and norethisterone.The pyridine, a limited solvent because of the toxicity to operator and the environment, was used in the literature process.Through the experiment research, the sodium acetate water solution was found successfully to replace the pyridine, and the adding quantity and the reaction time have been researched.The optimal process was got using the sodium acetate to replace the pyridine, the quality ratio 0.5:1, react 1 h at 50-60 °C and then reflux for 2 h.The green synthesis was realized, and yield was increased obviously.

Yaowu Fenxi Zazhi

Simultaneous determination of cephradine and arginine by HPLC

作者: Zeng, Hui ; Liu, Xuebin

Simultaneous determination of cephradine and arginine by HPLC was reported.The Spherisorb C₁₈ column (5 μm, 4.6 mm x 250 mm) was used.The mobile phase consisted of acetonitrile-acetate buffer solution (12:88), the detection wavelength was at 200 nm.7-ADCA (7-aminodesacetoxycephalosporanic acid) and dihydrophenylglycine, and cephalexin had no influence on the assay of the components.

Jinri Yaoxue

Synthetic technology of (9α,13α,14α)-3-methoxy-17-methylmorphinan (dextromethorphan)

作者: Ke, Ling-jin ; Tian, Hong-tao

A method for the synthesis of the title compound [i.e., (9α,13α,14α)-3-methoxy-17-methylmorphinan] is reported here.

100 项与广州白云山医药集团股份有限公司白云山化学制药厂相关的药物交易

登录后查看更多信息

100 项与广州白云山医药集团股份有限公司白云山化学制药厂相关的转化医学

登录后查看更多信息